Andusomeran

Possibly Marketed Outside US

Approval Year

Substance Class	Nucleic Acid Created by `admin` on `Sat Dec 16 19:54:17 GMT 2023` Edited by `admin` on `Sat Dec 16 19:54:17 GMT 2023`
Nucleic Acid Type	mRNA VACCINE
Nucleic Acid Subtype	VIRAL ENVELOPE PROTEIN
Sequence Origin	VIRAL
Sequence Type	COMPLETE
Record UNII	4F9QRS7ZV2
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CX-038839 Omicron (XBB.1.5)

Preferred Name

English

Andusomeran

Official Name

English

CX-038839 (COVID-19 Omicron subvariant Kraken) prefusion spike protein mRNA

Common Name

English

CX-038839

Code

English

CX-038839 (COVID-19 Omicron subvariant XBB.1.5) prefusion spike protein mRNA

Common Name

English

andusomeran [INN]

Common Name

English

RNA (recombinant 5′-(m7G-(5′→5′)-ppp-Gm)-capped all uridine→N1-methylpseudouridine-substituted severe acute respiratory syndrome coronavirus 2 pre-fusion spike glycoprotein [982-proline,983-proline] XBB.1.5 variant plus 5′- and 3′-untransla

Common Name

English

messenger RNA (mRNA), 5'-capped, encoding a full-length, codon-optimised pre-fusion stabilised conformation variant (K982P and V983P) of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) spike (S) glycoprotein (Omicron variant XBB.1.5; bas

Common Name

English

Code System Code Type Description

CAS

2918977-08-7

Created by admin on Sat Dec 16 19:54:17 GMT 2023 , Edited by admin on Sat Dec 16 19:54:17 GMT 2023

PRIMARY

INN

13097

Created by admin on Sat Dec 16 19:54:17 GMT 2023 , Edited by admin on Sat Dec 16 19:54:17 GMT 2023

PRIMARY

FDA UNII

4F9QRS7ZV2

Created by admin on Sat Dec 16 19:54:17 GMT 2023 , Edited by admin on Sat Dec 16 19:54:17 GMT 2023

PRIMARY

Sugar	Site Range	Site Count
D-Ribose (RNA)	1_1-1_4101	4101 / 4101

Linkage	Site Range	Site Count
Phosphate	1_2-1_4101	4100 / 4100

Related Record Type Details


					B6L4N5Z4GH

SARS-COV2

TARGET ORGANISM->VACCINE ANTIGEN

Amount:

Related Record Type Details


					4F9QRS7ZV2

Andusomeran

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
NUCLEOSIDE_SUBSTITUTION			U		N1-METHYLPSEUDOURIDINE	09RAD4M6WF
NUCLEOTIDE SUBSTITUTION	[1_1]				5'-GUANOSINE-M-RNA-CAP-1-3'-PHOSPHATE	T0HQY09X7B